Hypertrophic Cardiomyopathy: Is a ‘Cure’ Coming . . . Or Is It Already Here?

Over its 60-year history, a consistent theme attached to hypertrophic cardiomyopathy (HCM) has been controversy concerning its prevalence, clinical course, and expectations for treatment benefit.1 Once regarded as rare and ominous, HCM is now recognized as a common genetic disease with worldwide distribution, broad spectrum, and clinical outcome transformed over the last several years by the introduction of management strategies that favorably alter its natural history and provide a high level of care for the vast majority of patients.

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *